Feedback / Questions
BST02 - Biosyngen
https://www.prnewswire.com/news-releases/biosyngen-announces-fda-fast-track-designation-for-bst02-in-treatment-of-liver-cancer-302050377.html
Feb 1, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next